Table of Contents
ISRN Oncology
Volume 2012, Article ID 674523, 8 pages
http://dx.doi.org/10.5402/2012/674523
Clinical Study

Epidemiological Characteristics and Survival Studies of Rhabdomyosarcoma in East Egypt: A Five-Year Multicenter Study

1Pediatric Hematology/Oncology Units, Zagazig University, Zagazig 44111, Egypt
2Pediatric Hematology/Oncology Units, Mansoura University, Mansoura 35516, Egypt

Received 13 February 2012; Accepted 20 March 2012

Academic Editors: M. Al-Sarraf and C. N. Qian

Copyright © 2012 M. A. Badr et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Ries, C. L. Kosary, B. F. Hankey, B. A. Miller, L. Clegg, and B. K. Edwards, Eds., SEER Cancer Statistics Review, 1973–1996, National Cancer Institute, Bethesda, Md, USA, 1999.
  2. S. Ognjanovic, A. M. Linabery, B. Charbonneau, and J. A. Ross, “Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975–2005,” Cancer, vol. 115, no. 18, pp. 4218–4226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Wexler and L. Helman, “Rhabdomyosarcoma and the undifferentiated sarcomas,” in Principles and Practice of Pediatric Oncology, P. Pizzo and D. Poplack, Eds., pp. 799–829, Lippincott-Raven, Philadelphia, Pa, USA, 3rd edition, 1997. View at Google Scholar
  4. A. S. Pappo, D. N. Shapiro, W. M. Crist, and H. M. Maurer, “Biology and therapy of pediatric rhabdomyosarcoma,” Journal of Clinical Oncology, vol. 13, no. 8, pp. 2123–2139, 1995. View at Google Scholar · View at Scopus
  5. E. S. Wiener, “Rhabdomyosarcoma,” in Pediatric Surgery, J. A. O’Neill, M. I. Rowe, J. L. Grosfeld et al., Eds., pp. 431–445, Mosby, St Louis, Miss, USA, 5th edition, 1998. View at Google Scholar
  6. M. Atlas, “Rhabdomyosarcoma and other soft tissue sarcomas,” in Manual of Pediatric Hematology and Oncology, P. Lanzkowsky, Ed., vol. 20, pp. 561–584, Elsevier, London, UK, 4th edition, 2005. View at Google Scholar
  7. J. A. Punyko, A. C. Mertens, K. S. Baker, K. K. Ness, L. L. Robison, and J. G. Gurney, “Long-term survival probabilities for childhood rhabdomyosarcoma: a population-based evaluation,” Cancer, vol. 103, no. 7, pp. 1475–1483, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. D. R. Boué, D. M. Parham, B. Webber, W. M. Crist, and S. J. Qualman, “Clinicopathologic study of ectomesenchymomas from intergroup rhabdomyosarcoma study groups III and IV,” Pediatric and Developmental Pathology, vol. 3, no. 3, pp. 290–300, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Treuner and E. Koscielniak, “Cooperative Weichteilsarkom Studiengruppe CWS 2002-P protocol,” Study Protocol, 2003.
  10. T. Shouman, I. El-Kest, K. Zaza, M. Ezzat, H. William, and I. Ezzat, “Rhabdomyosarcoma in childhood: a retrospective analysis of 190 patients treated at a single institution,” Journal of the Egyptian National Cancer Institute, vol. 17, no. 2, pp. 67–75, 2005. View at Google Scholar · View at Scopus
  11. W. M. Crist, J. R. Anderson, J. L. Meza et al., “Intergroup Rhabdomyosarcoma Study-IV: results for patients with nonmetastatic disease,” Journal of Clinical Oncology, vol. 19, no. 12, pp. 3091–3102, 2001. View at Google Scholar · View at Scopus
  12. H. H. Abd El-Aal, E. E. Habib, and M. M. Mishrif, “Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001),” Journal of the Egyptian National Cancer Institute, vol. 18, no. 1, pp. 51–60, 2006. View at Google Scholar · View at Scopus
  13. L. Hessissen, L. Kanouni, A. Kili et al., “Pediatric rhabdomyosarcoma in Morocco,” Pediatric Blood and Cancer, vol. 54, no. 1, pp. 25–28, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Hosoi, S. Teramukai, Y. Matsumoto et al., “A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan,” International Journal of Clinical Oncology, vol. 12, no. 2, pp. 137–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Koscielniak, D. Harms, G. Henze et al., “Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German cooperative soft tissue sarcoma study CWS-86,” Journal of Clinical Oncology, vol. 17, no. 12, pp. 3706–3719, 1999. View at Google Scholar · View at Scopus
  16. W. Lawrence Jr., D. M. Hays, R. Heyn et al., “Lymphatic metastases with childhood rhabdomyosarcoma. A report from the Intergroup Rhabdomyosarcoma Study,” Cancer, vol. 60, no. 4, pp. 910–915, 1987. View at Google Scholar
  17. L. Mandell, F. Ghavimi, M. LaQuaglia, and P. Exelby, “Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma,” Medical and Pediatric Oncology, vol. 18, no. 6, pp. 466–471, 1990. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Rodary, E. A. Gehan, F. Flamant et al., “Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: a report from the International Rhabdomyosarcoma Workshop,” Medical and Pediatric Oncology, vol. 19, no. 2, pp. 89–95, 1991. View at Google Scholar · View at Scopus
  19. J. C. Breneman, E. Lyden, A. S. Pappo et al., “Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma—a report from the Intergroup Rhabdomyosarcoma Study IV,” Journal of Clinical Oncology, vol. 21, no. 1, pp. 78–84, 2003. View at Google Scholar · View at Scopus